XyloCor
xylocor.com
Actively hiring
Biotechnology
Cell & Gene Therapy
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
Jeito Capital, Lumira Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Jeito Capital 
Lumira Ventures 
Sofinnova Investments Similar startupsby what they do, their industry and backers
Redefining Complement Therapies. Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for…
A gene therapy approach to treating chronic, age-related disease. Targeting the root causes of aging to create life-changing treatments for…
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Top of page Our Story Fuse Vectors was born from a shared vision to build better viral vectors for gene therapy. Drawing on their industry…
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of…
Instant Quantification of genetic modifications for Cell and Gene Therapies.
Overview
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our commitment to advancing novel therapies for coronary artery disease.